Sonoma PharmaceuticalsSNOA
13F holders, Q2 2025 (June 30)14holders +2
3new positions
2sold out
1famous investor
$2.85avg. 13F price*
At the end of Q2 2025, 14 institutions reported holding Sonoma Pharmaceuticals Inc. (SNOA) in their 13F filings, up 2 from Q1 2025. 3 opened new positions and 2 sold out. The largest holders were Heron Bay Capital Management ($96K), Renaissance Technologies ($51K) and Geode Capital Management, LLC ($51K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Sonoma Pharmaceuticals Inc.
- CUSIP
- 83558L303
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $147K |
| Exits | 2 | $27K |
All 13F filers, Q1 2025 → Q2 2025: 64,962 shares bought and 13,119 shares sold, net +51,843 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Heron Bay Capital Management | 0.02% | New | 33,782 | $96K |
| Renaissance Technologies | 0.00% | New | 17,800 | $51K |
| Geode Capital Management, LLC | 0.00% | Add +4.8% | 17,617 | $51K |
| UBS Group AG | 0.00% | Add +678.5% | 14,417 | $41K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -30.9% | 1,000 | $3K |
| JPMorgan Chase & Co. | 0.00% | Reduce -13.0% | 120 | $344 |
| BlackRock, Inc. | 0.00% | No change | 113 | $321 |
| US Bancorp \de | 0.00% | No change | 25 | $71 |
| Bank of America Corp. | 0.00% | Add +13.3% | 17 | $49 |
| Morgan Stanley | 0.00% | No change | 4 | $11 |
| Allworth Financial LP | 0.00% | No change | 3 | $9 |
| Quaker Wealth Management, LLC | 0.00% | — | 3 | $9 |
| Danske Bank A/S | 0.00% | No change | 1 | $3 |
| Cwm, LLC | 0.00% | New | 1 | $0 |
"% of holder's portfolio" is SNOA's weight in each manager's 13F, not the share of Sonoma Pharmaceuticals Inc. the manager owns.